Related references
Note: Only part of the references are listed.Effect of Alemtuzumab (CAMPATH 1-H) in patients with inclusion-body myositis
Marinos C. Dalakas et al.
BRAIN (2009)
Inclusion-body myositis: muscle-fiber molecular pathology and possible pathogenic significance of its similarity to Alzheimer's and Parkinson's disease brains
Valerie Askanas et al.
ACTA NEUROPATHOLOGICA (2008)
Rabbits fed cholesterol-enriched diets exhibit pathological features of inclusion body myositis
Xuesong Chen et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2008)
A high incidence of disease flares in an open pilot study of infliximab in patients with refractory inflammatory myopathies
M. Dastmalchi et al.
ANNALS OF THE RHEUMATIC DISEASES (2008)
Inclusion body myositis: new insights into pathogenesis
Michael J. Garlepp et al.
CURRENT OPINION IN RHEUMATOLOGY (2008)
Inclusion body myositis functional rating scale: A reliable and valid measure of disease severity
C. E. Jackson et al.
MUSCLE & NERVE (2008)
Sporadic inclusion body myositis - diagnosis, pathogenesis and therapeutic strategies
Marinos C. Dalakas
NATURE CLINICAL PRACTICE NEUROLOGY (2006)
Pilot trial of etanercept in the treatment of inclusion-body myositis
RJ Barohn et al.
NEUROLOGY (2006)
International consensus guidelines for trials of therapies in the idiopathic inflammatory myopathies
CV Oddis et al.
ARTHRITIS AND RHEUMATISM (2005)
International consensus on preliminary definitions of improvement in adult and juvenile myositis
LG Rider et al.
ARTHRITIS AND RHEUMATISM (2004)
Incidence of hospitalized rhabdomyolysis in patients treated with lipid-lowering drugs
DJ Graham et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
Oral simvastatin treatment in relapsing-remitting multiple sclerosis
T Vollmer et al.
LANCET (2004)
Proposed pathogenetic cascade of inclusion-body myositis:: importance of amyloid-β, misfolded proteins, predisposing genes, and aging
V Askanas et al.
CURRENT OPINION IN RHEUMATOLOGY (2003)
Anti-T-lymphocyte globulin treatment in inclusion body myositis - A randomized pilot study
C Lindberg et al.
NEUROLOGY (2003)
Statins induce angiogenesis, neurogenesis, and synaptogenesis after stroke
JL Chen et al.
ANNALS OF NEUROLOGY (2003)
Proposed preliminary core set measures for disease outcome assessment in adult and juvenile idiopathic inflammatory myopathies
FW Miller et al.
RHEUMATOLOGY (2001)
Statins selectively inhibit leukocyte function antigen-1 by binding to a novel regulatory integrin site
G Weitz-Schmidt et al.
NATURE MEDICINE (2001)
Simvastatin strongly reduces levels of Alzheimer's disease β-amyloid peptides Aβ42 and Aβ40 in vitro and in vivo
K Fassbender et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Pravastatin treatment increases collagen content and decreases lipid content, inflammation, metalloproteinases, and cell death in human carotid plaques - Implications for plaque stabilization
M Crisby et al.
CIRCULATION (2001)
Share Paper
